Companies: 10,795·Total market cap: $144.5T
Progyny, Inc.

Progyny, Inc.

PGNYNASDAQHealthcare● Active
$25.92
+$0.06(+0.23%)
Market Cap$2.0B
P/E Ratio
52W High$28.75
52W Low$16.1
Overview

Progyny, Inc. (PGNY) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001551306 · PGNY · NASDAQ · as of Jun 10, 2026

Filing snapshot

910
Total Filings
SCHEDULE 13G/A
Latest Form
2026-06-08
Most Recent
2019
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001551306 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-02-27
Fiscal Year End
Feb 27, 2026
Accession No.
0001551306-26-000020
Primary Document
pgny-20251231.htm
Source: data.sec.gov · CIK 0001551306 · Accession 0001551306-26-000020

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-08
8-KCurrent Report
8-K
2026-05-27Material Event
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-06-08
View
8-KCurrent Report
8-K
2026-05-27
View
8-KCurrent Report
8-K
2026-05-26
View
10-QQuarterly Report
10-Q
2026-05-08
View
8-KCurrent Report
8-K
2026-05-07
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-04-29
View
ARSARS
ARS
2026-04-10
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-10
View
DEF 14AProxy Statement
DEF 14A
2026-04-10
View
PRE 14APRE 14A
PRE 14A
2026-03-31
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-03-27
View
8-KCurrent Report
8-K
2026-03-13
View
S-8Employee Stock Plan Registration
S-8
2026-02-27
View
10-KAnnual Report
10-K
2026-02-27
View
8-KCurrent Report
8-K
2026-02-26
View
Showing 1–15 of 209 filingsForm 4 / 144 hidden· 910 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001551306  |  Exchange: NASDAQ · Healthcare

Progyny, Inc. (NASDAQ: PGNY) has submitted 910 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2019. As a Healthcare sector company with CIK 0001551306, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Progyny, Inc.'s most comprehensive regulatory disclosure. The most recent Progyny, Inc. 10-K was filed on 2026-02-27 for fiscal year ending 2026. Historical PGNY 10-K annual reports are available from 2012 through 2026.

Investors researching Progyny, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-10

Frequently Asked Questions

PGNY SEC Filings · 8 questions

Progyny, Inc. (PGNY) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 910 filings and access original documents at no cost. Progyny, Inc.'s CIK is 0001551306.

PGNY SEC filingsProgyny, Inc. SEC documentsfind PGNY 10-K